A critical advance in cancer investigation is arising with the use of nanobodies to reactivate damaged p53. This crucial malignant protector protein is frequently disabled in many kinds of cancer, causing uncontrolled https://totalbookmarking.com/story22004570/mini-antibodies-restore-tumor-suppressor-p53-a-promising-pathway-for-cancer-management